Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus.
For a recently developed E2 subunit vaccine against classical swine fever (CSF), the reduction in transmission, at different moments after vaccination, was assessed by animal experiments and statistical calculations. Two experiments were performed to estimate the reproduction ratio R. Experiment 1 consisted of three groups and experiment 2 of two groups each of 10 pigs. In four of these groups, all pigs were vaccinated intramuscularly with the vaccine. The pigs in the fifth group remained unvaccinated (control group). After treatment, half of each group was intranasally inoculated with the virulent CSFV strain Brescia. In the vaccine groups, the following vaccination-challenge intervals were applied: 14, 14, 10, and 7 days, respectively. The occurrence of (contact-) infection was determined using the E(rns) ELISA. In the 7-days interval group and in the control group, virus transmission to all contact pigs occurred, indicating R1. Neither in the two 2-week interval groups nor in the 10-day interval group did contact-infections occur. Hence, the estimated R is less than one, which indicates that an epidemic would fade out. Therefore, the E2 subunit vaccine may be an efficacious tool in a control program during an outbreak of CSF as from 10 days after vaccination.
Bouma
A
A
Department of Mammalian Virology, Institute for Animal Science and Health (ID-DLO), P.O. Box 65, 8200, AB Lelystad, The Netherlands. A.Bouma@ID.DLO.NL
De Smit
A J
AJ
De Jong
M C
MC
De Kluijver
E P
EP
Moormann
R J
RJ
D000818:Animals; D006691:Classical Swine Fever / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission / Q000821:virology; D006692:Classical Swine Fever Virus / Q000276:immunology*; D007115:Immunization Schedule; D013552:Swine; D014759:Viral Envelope Proteins / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology / Q000627:therapeutic use*
D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C087086:glycoprotein E2, classical swine fever virus